Vaccines & Disease · Hepatitis A

Hepatitis A & Hepatitis A Vaccine Quick Facts

Published October 12, 2021 · 2 min read
01

Hepatitis A Quick Facts

  • Hepatitis A is a viral disease of the liver that is contracted through contact with, or by swallowing human fecal waste, generally through eating or drinking contaminated food and/or water.1 The virus is typically spread when people eat or drink something that has been contaminated with the virus;2
  • Hepatitis A thrives in areas that lack proper sanitation, clean drinking water or where personal hygiene habits are poor.3 The virus can remain in the environment for several months. Formalin, chlorine, and high temperatures can kill the virus.45 Hepatitis A can be found in all areas of the world but is often endemic in Africa, Asia, the Western Pacific, the Middle East, and Central and South America;6
  • Symptoms of hepatitis A generally appear between two and seven weeks following exposure to the virus and infected individuals can spread the virus to others for up to two weeks before showing symptoms.7 Symptoms often occur suddenly and may include fatigue, abdominal and/or joint pain, loss of appetite, fever, nausea, jaundice, dark urine, clay-colored bowel movements, and diarrhea. Younger children often show no clinical symptoms of infection. Only lab testing can confirm a diagnosis of hepatitis A;8
  • Complications and deaths from hepatitis A are rare9 and most infected individuals recover fully within two months. In approximately 10 to 15 percent of individuals, symptoms may last up to six months.10
02

Hepatitis A Vaccine Quick Facts

  • There are three hepatitis A containing vaccines available for use in the United States. VAQTA,11 an inactivated hepatitis A virus vaccine, manufactured by Merck; HAVRIX,12 an inactivated hepatitis A virus vaccine manufactured by GlaxoSmithKline; and TWINRIX,13 a combination vaccine containing both inactivated hepatitis A virus vaccine (HAVRIX) and recombinant hepatitis B vaccine (ENGERIX-B), manufactured by GlaxoSmithKline. VAQTA, HAVRIX, and TWINRIX were developed using aborted fetal cells.141516
  • Common side effects from the hepatitis A vaccine include soreness around injection site, headache, low-grade fever, and fatigue.17 Reported serious side effects following hepatitis A (VAQTA, HAVRIX, & TWINRIX) vaccination include anaphylaxis, thrombocytopenia, encephalopathy, multiple sclerosis, Guillain-Barre Syndrome, and more.181920
  • Adequate and well-controlled studies on the use of hepatitis A vaccine during pregnancy have not been conducted and it is not known whether the vaccine is present in breastmilk. Studies have not been conducted to determine whether hepatitis A vaccine can impair fertility, or whether the vaccine is carcinogenic or mutagenic.212223
  • Using the MedAlerts search engine, as of January 2, 2026, there have been 54,467 reports of hepatitis A vaccine reactions, with over 25 percent (14,019) of reaction occurring in children under 3 years of age. Reports made to the federal Vaccine Adverse Events Reporting System (VAERS) note hospitalizations, injuries and deaths following hepatitis A vaccinations, including 196 related deaths, 3,860 hospitalizations, and 1,051 related disabilities.
  • On December 1, 2004, hepatitis A vaccine was added to the National Vaccine Injury Compensation Program’s (VICP) Vaccine Injury Table, as published in the Federal Register. As of December 1, 2025, there had been 220 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following hepatitis A vaccination, including 9 deaths and 211 serious injuries.
Food & Drug Administration (FDA)

IMPORTANT NOTE: NVIC encourages you to become fully informed about Hepatitis A and the Hepatitis A vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

References
  1. 1US National Library of Medicine MedlinePlus. Hepatitis A. Jan. 11, 2021.
  2. 2WebMD. Hepatitis A (Hep A). Dec. 5, 2021.
  3. 3World Health Organization (WHO). Hepatitis A. June 24, 2022.
  4. 4Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  5. 5US Centers for Disease Control and Prevention. How is the hepatitis A virus (HAV) killed? July 28, 2020.
  6. 6Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  7. 7US Centers for Disease Control and Prevention. What are the symptoms of hepatitis A. July 28, 2020.
  8. 8Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  9. 9Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  10. 10US Centers for Disease Control and Prevention. When symptoms occur, how long do they last? July 28, 2020.
  11. 11Merck Sharp & Dohme Corp. Package Insert – VAQTA. U.S. Food and Drug Administration Oct. 26, 2020.
  12. 12GlaxoSmithKline Biologicals. Package Insert – Havrix. U.S. Food and Drug Administration Dec. 6, 2021.
  13. 13GlaxoSmithKline Biologicals. Package Insert – TWINRIX. U.S. Food and Drug Administration Oct. 3, 2019.
  14. 14Merck Sharp & Dohme Corp. Package Insert – VAQTA. U.S. Food and Drug Administration Oct. 26, 2020.
  15. 15GlaxoSmithKline Biologicals. Package Insert – Havrix. U.S. Food and Drug Administration Dec. 6, 2021.
  16. 16GlaxoSmithKline Biologicals. Package Insert – TWINRIX. U.S. Food and Drug Administration Oct. 3, 2019.
  17. 17US Centers for Disease Control and Prevention. Hepatitis A VIS. Oct. 15, 2021.
  18. 18Merck Sharp & Dohme Corp. Package Insert – VAQTA. U.S. Food and Drug Administration Oct. 26, 2020.
  19. 19GlaxoSmithKline Biologicals. Package Insert – Havrix. U.S. Food and Drug Administration Dec. 6, 2021.
  20. 20GlaxoSmithKline Biologicals. Package Insert – TWINRIX. U.S. Food and Drug Administration Oct. 3, 2019.
  21. 21Merck Sharp & Dohme Corp. Package Insert – VAQTA. U.S. Food and Drug Administration Oct. 26, 2020.
  22. 22GlaxoSmithKline Biologicals. Package Insert – Havrix. U.S. Food and Drug Administration Dec. 6, 2021.
  23. 23GlaxoSmithKline Biologicals. Package Insert – TWINRIX. U.S. Food and Drug Administration Oct. 3, 2019.
Select disease / vaccine